Revive Therapeutics Proposes $1M Private Placement

Key Facts

Amid funding challenges for small biotech firms, Revive Therapeutics announced a proposed private placement of up to 31.25 million units at $0.032 per unit, aiming to raise approximately $1 million. Proceeds will be used for working capital and general corporate purposes, according to a company statement.

Private placements are a common financing tool for development-stage biotech companies but typically dilute existing shareholders. The company is expected to focus on advancing its pipeline, with no immediate catalysts on the economic calendar for this micro-cap stock.